#elanco

#elanco

He came here, and he realized that cows here were sleeping on some sort of mattress... he was shocked by that.

The public comment period is an important opportunity for producers across Canada to review the draft Code and provide feedback on how it applies to their operations. Producer perspectives from across the country help ensure the Code reflects the diversity of Canadian beef production systems and remains practical for producers who raise cattle.

Data-driven approaches in livestock health management can significantly enhance decision-making processes, leading to improved animal welfare and productivity in the agriculture sector.

Novo Nordisk plans to deploy advanced artificial intelligence capabilities to analyze complex datasets, identify promising drug candidates, and reduce the time required to move from research to patient.

Citi's thesis rests on the 'humanization' of pets. The firm says the humanization pet trend is real and should drive more spending, a view supported by data showing nearly 40% of dogs of any age or size may be affected by OA pain and up to 40% of all cats have clinical signs of OA.

"I think about it like a piggy bank. Some meetings, tasks, and decisions draw heavily from it, particularly long discussions that go in circles..."

Bayer is supplementing human security patrols around its 8,000 acre Hawaiian corn farm with robotic security dogs, supplied by the tech firm Asylon. The Asylon dogs are meant to guard the company's precious maize from vandals, wildfires, wild fauna, and other hazards around the clock.

Amazon Pharmacy's decision to stock Foundayo at One Medical kiosks represents a significant shift in how Americans can access weight-loss medications, with plans for same-day home delivery.

We are continuing to execute our prediction markets treasury strategy, and we are pleased that Lind provided us with substantial capital, stated Shai Novik, Executive Chairman of Enlivex.

I went to ChatGPT and came up with a plan on how to do this. He also used AlphaFold, an AI tool from Google's DeepMind, to find mutated proteins that could be potential targets for treatment. While an immunotherapy treatment that looked like a good fit for Rosie was identified, the drugmaker wouldn't provide it.

Guggenheim analyst Seamus Fernandez raised his firm's price target on AstraZeneca to 16,500 GBp from 16,000 GBp, maintaining a Buy rating after updating the firm's model ahead of Q1 earnings.

The Competition and Markets Authority found that consumers have overpaid roughly £1 billion in veterinary fees over five years, highlighting a significant issue in the market.

"We're bringing over 20 new products... in the adjuvant space, the crop protection space, seed treatment, as well as the plant nutrition space," Walker states, emphasizing the significant volume of innovations for the upcoming year.

X4 Pharmaceuticals drew a fresh initiation from Guggenheim, which assigned a Buy rating and $12 price target, framing the company as a "differentiated hematology play" with significant upside in the next 18 months. The firm's thesis centers on mavorixafor, a potential first-in-class oral CXCR4 antagonist already approved for WHIM syndrome and currently in Phase 3 development for primary chronic neutropenia.

For someone aiming to end the global livestock industry, Bruce Friedrich begins his new book called Meat in disarming fashion: I'm not here to tell anyone what to eat. You won't find vegetarian or vegan recipes in this book, and you won't find a single sentence attempting to convince you to eat differently. This book isn't about policing your plate.

Last November, the UK government announced a bold plan to phase out animal testing in some areas of research. Animal tests for skin irritation are scheduled for elimination this year, and some studies on dogs should be slashed by 2030. The long-term vision is 'a world where the use of animals in science is eliminated in all but exceptional circumstances'.

RBC Capital analyst Luca Issi upgraded the stock to Outperform from Sector Perform with a price target of $35, up from $11. Wells Fargo also upgraded uniQure to Overweight from Equal Weight with a $60 price target. The catalyst: the departure of Vinay Prasad from the FDA. RBC views this as a positive for uniQure, noting it is "not inconceivable" that the FDA reverts to its prior stance, and believes Prasad's departure is likely to open up a more balanced discussion on risk/reward for Huntington's disease.

About 40% of Chinese employees stay in one job for less than two years, according to a Hay Group study. In India, annual turnover of 50% or more is not unusual. That's clearly a problem, not only because constantly recruiting and training people over and over again is expensive, but because it's disruptive. Continuity, let alone growth, can be tough to maintain when half your team is made up of brand-new faces every few months.

Oppenheimer frames Ocugen as an emerging gene therapy leader in blinding ocular disorders, with the investment thesis centered squarely on the company's lead asset, OCU400. The firm views a potential 2027 approval as a near-term entry point into what it describes as a 'sizable and poorly-met rare disease market opportunity.' The core appeal is OCU400's gene-agnostic mechanism: unlike the only existing approved retinitis pigmentosa therapy, Luxturna, which targets just one of 100+ RP-associated genes, OCU400 is designed to address the broad RP patient population with a single one-time injection.

Conrad says the Alberta government is mindful of the implications for long-standing research programs and the people affected by the decision. "It's early, we're concerned, we're actively talking and we'll do our very best to optimize," he says, noting that Alberta is a co-investor in some of the work conducted at Lacombe and sees the site as a critical part of the province's agricultural research ecosystem.

The company on February 11 announced it had raised $100 million in Series C funding as it pursues FDA approval of LOY-002, a beef-flavored daily prescription pill designed to extend the healthy lifespan of senior dogs. The drug mimics some of the effects of a calorie-restricted diet in addressing age-related metabolic issues without requiring pet owners to cut their dogs' food supply or curbing canine appetites.

The pricing data coincides with a study which found that one-third of UK pet owners don't have insurance, with cost cited as one of the biggest factors. It is estimated that 60% of UK households about 17 million have a pet, and the high costs of ownership have been in the news lately. Last month, the government announced a big shake-up of the UK vet sector that ministers said should push down costs for pet owners by requiring practices to make their pricing clearer.

Central to this window is the delivery of colostrum, which provides essential antibodies and energy. To ensure success, she recommends following a "two by four" rule. "...getting colostrum in within those first four hours is really critical to getting the best absorption," says Fowler, specifying that calves should receive two litres by four hours of age and an additional two litres by 12 hours. She points out that failure of passive transfer can lead to a 10-kilogram decrease in weaning weight.